Sarah Sanowar is a scientific leader in biologics, currently serving as a Principal Scientist at Dren Bio, Inc. Her distinguished career includes pivotal roles at Alphabets Verily, Amgen, and Genentech, where she drove antibody discovery, developed protein display technologies, and led research teams. She earned her PhD from McGill University.
Sarah is deeply engaged in the scientific community, actively following the latest research trends and attending thoughtful drug discovery conferences. She is passionate about the intersection of wet lab experimentation and computational biology, particularly in designing binders for challenging protein targets.
She holds patents for her work at Genentech on bispecific antibodies, demonstrating her innovative contributions to therapeutic antibody engineering.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.